Sort
10,766 grants matching “checkpoint inhibitor”
Mre11-Dependent DNA Damage Responses in Breast Cancer Pathogenesis
$422,092Gaorav P. Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2025 · CA
Project 2: Deciphering the Dynamic Evolution of the Tumor-Immune Interface
$422,043Forest M White · Massachusetts Institute Of Technology · U54 · FY2024 · CA
The structural function of ATR in development, oncogenesis and cancer therapy
$421,825Shan Zha · Columbia University Health Sciences · R01 · FY2020 · CA
Targeting Transcriptional Regulators for Immunotherapy of Acute Myeloid Leukemia
$421,762Marcin Kortylewski · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Targeting a Novel Secreted Immune Checkpoint to Enhance Liver Cancer Immunotherapy
$421,685Yalan Deng · University Of Tx Md Anderson Can Ctr · R21 · FY2025 · CA
Impact of senescence on T-cell function and immunotherapeutic response
$421,651Christin E Burd · Ohio State University · R01 · FY2020 · AG
Improving anti-tumor immunity in advanced breast cancer by targeting solid stress
$421,414Dennis Jones · Boston University Medical Campus · R01 · FY2025 · CA
Targeting NQO1+ tumor to trigger innate and adaptive immunity
$421,360Xiumei Huang · Indiana University Indianapolis · R01 · FY2020 · CA
Project 2
$421,290David A Barbie · Dana-Farber Cancer Inst · P50 · FY2022 · CA
Impact of senescence on T-cell function and immunotherapeutic response
$421,203Christin E Burd · Ohio State University · R01 · FY2021 · AG
Impact of senescence on T-cell function and immunotherapeutic response
$421,203Christin E Burd · Ohio State University · R01 · FY2022 · AG
Signaling Pathways in Neuronal Cells
$421,202Marsha R Rosner · University Of Chicago · R01 · FY2009 · GM
Immunophenotype Integration for Monitoring T Cell Dynamics in Pancreatic Cancers
$421,042Won Jin Ho · Johns Hopkins University · R21 · FY2021 · CA
Ablating Liver Metastases with SBRT to Enhance Immune Checkpoint Blockade in Melanoma
$420,670Theodore S Lawrence · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
HPV AND ANTIGEN PRESENTING CELLS
$420,544W Martin Kast · University Of Southern California · R01 · FY2020 · CA
Harnessing the therapeutic potential of histotripsy focused ultrasound-induced immunogenic cancer cell death
$420,313Clifford Cho · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Encapsulated Cell Based Oncolytic Virus Therapy for Brain Tumors
$420,251Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2025 · NS
Preventing follicular lymphoma progression and transformation through precision therapy
$420,219Wendy Beguelin · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA
Analyzing genetic and environmental molecular mechanisms causing autoimmune thyroid diseases
$420,000Yaron Tomer · Albert Einstein College Of Medicine · R01 · FY2022 · DK
Analyzing genetic and environmental molecular mechanisms causing autoimmune thyroid diseases
$420,000Yaron Tomer · Albert Einstein College Of Medicine · R01 · FY2023 · DK
WEE1 inhibition and tumor immunity
$420,000Bin Zhang · Northwestern University At Chicago · R01 · FY2021 · CA
Nanocage-based systemic delivery of TGFb trap for immunomodulation of brain neoplasms
$419,968Jung Soo Suk · University Of Maryland Baltimore · R01 · FY2024 · NS
Role of microbial-modulated bile acid receptor signaling in breast cancer
$419,927Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · R01 · FY2023 · CA
Project 1: Improving Immunotherapy in pancreatic NETs
$419,863Dawn E Quelle · University Of Iowa · P50 · FY2025 · CA
Platelets-Mediated Delivery of Checkpoint Inhibitors for Post-Surgical Cancer Immunotherapy
$419,793Song Li · University Of California Los Angeles · R01 · FY2020 · CA